Literature DB >> 25896472

Pulmonary involvement in long-term mixed connective tissue disease: functional trends and image findings after 10 years.

Leticia Kawano-Dourado1, Bruno G Baldi1, Fernando U Kay2, Olivia M Dias1, Thais E H Gripp2, Paula S Gomes3, Ricardo Fuller4, Maria T C Caleiro4, Ronaldo A Kairalla1, Carlos R R Carvalho1.   

Abstract

OBJECTIVES: Interstitial lung disease (ILD) is highly prevalent in patients with mixed connective tissue disease (MCTD). However, little is known about the long-term progression of ILD in MCTD. The aims of this study were to describe pulmonary function test (PFT) and high-resolution computed tomography (HRCT) results in long-term MCTD patients, to measure changes in PFT and HRCT results over a 10-year period, and to ascertain correlations in functional and imaging data.
METHODS: In this retrospective cohort study, comparison between baseline and follow-up PFT and HRCT data was performed for 39 unselected consecutive MCTD patients.
RESULTS: At baseline, 51% of the patients had abnormal PFTs. Forced vital capacity (FVC) was slightly reduced at baseline (77% of predicted), but remained stable after 10 years. A relative decrease of 15% in the diffusion capacity for carbon monoxide (DLCO) was detected (from 84% to 71% of predicted, p<0.001). The median lower lobes ILD-HRCT score progressed from 7.5% at baseline to 11.2% at follow-up (p=0.02), and findings of traction bronchiolectasis and honeycombing increased (p<0.05). A moderate negative correlation was observed between functional parameters and quantification of image findings.
CONCLUSIONS: Functional and radiologic alterations suggestive of ILD in long-term MCTD patients are prevalent, mild, and progressed slightly over time. The most sensitive parameters for detecting subtle progression of ILD in MCTD patients are trends in DLCO, quantification of lower-lobes disease by HRCT (lower-lobes %ILD-HRCT score), and qualitative analysis of HRCT imaging.

Entities:  

Mesh:

Year:  2015        PMID: 25896472

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  4 in total

1.  Mixed connective tissue disease complicated by heart failure in Ile-Ife, Nigeria: management challenges in a resource-limited economy.

Authors:  Oladapo A Adewuya; Rasaaq A Adebayo; Adeola I Ajibade; Gbenga J Odunlami; Anthony O Akintomide; Suraj A Ogunyemi; Olufemi E Ajayi; Adebola O Adetiloye; Adeleye D Omisore; Oladipo A Olanipekun; Adeyinka O Owolabi; Ifeoluwa Amjo; Olumide A Akinyele; Abayomi O Bamgboje; Michael O Balogun
Journal:  Int Med Case Rep J       Date:  2018-11-02

Review 2.  Contribution of pulmonary function tests (PFTs) to the diagnosis and follow up of connective tissue diseases.

Authors:  Nicola Ciancio; Mauro Pavone; Sebastiano Emanuele Torrisi; Ada Vancheri; Domenico Sambataro; Stefano Palmucci; Carlo Vancheri; Fabiano Di Marco; Gianluca Sambataro
Journal:  Multidiscip Respir Med       Date:  2019-05-15

3.  Associations between nailfold capillaroscopy findings and interstitial lung disease in patients with mixed connective tissue disease.

Authors:  Magdalena Celińska-Löwenhoff; Maciej Pastuszczak; Karolina Pełka; Magdalena Stec-Polak; Anna Wojas-Pelc; Jacek Musiał
Journal:  Arch Med Sci       Date:  2019-01-11       Impact factor: 3.318

Review 4.  Pharmacological Interventions for Pulmonary Involvement in Rheumatic Diseases.

Authors:  Eun Ha Kang; Yeong Wook Song
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.